Mitochondrial dysfunction and reduced prostaglandin synthesis in skeletal muscle of Group VIB Ca2+-independent phospholipase A 2γ-deficient mice

Journal of Lipid Research

Volumn 51, Issue 10, 2010, Pages 3003-3015

  Yoda, Emiko ^a   Hachisu, Keiko ^a   Taketomi, Yoshitaka ^a,b   Yoshida, Kotomi ^a   Nakamura, Masanori ^a   Ikeda, Kazutaka ^c   Taguchi, Ryo ^c   Nakatani, Yoshihito ^a   Kuwata, Hiroshi ^a   Murakami, Makoto ^a,b   Kudo, Ichiro ^a   Hara, Shuntaro ^a  

^a SHOWA UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cardiolipin; Mitochondria; Muscle; Phospholipids

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CALCIUM INDEPENDENT PHOSPHOLIPASE A2 GAMMA; CARDIOLIPIN; MALONALDEHYDE; PHOSPHOLIPID; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTANOID; THROMBOXANE B2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL SWELLING; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON MICROSCOPY; ENZYME DEFICIENCY; FEMALE; GENE DISRUPTION; GENE INDUCTION; GROWTH RETARDATION; KNOCKOUT MOUSE; KYPHOSIS; LIPID PEROXIDATION; MALE; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MOUSE; MUSCLE ATROPHY; MUSCLE WEAKNESS; MYOFILAMENT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN FUNCTION; SKELETAL MUSCLE;

ANIMALS; FEMALE; GROUP VI PHOSPHOLIPASES A2; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; MONOCYTES; MUSCLE, SKELETAL; OXIDATIVE STRESS; PROSTAGLANDINS;

EID: 77956797735     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M008060     Document Type: Article

References (71)

1. 2 enzymes. Prostaglandins Other Lipid Mediat. 68-69: 3-58.
2. Murakami, M., and I. Kudo. 2001. Diversity and regulatory functions of mammalian secretory phospholipase A2s. Adv. Immunol. 77: 163-194. (Pubitemid 33703706)
3. 2 structure/function, mechanism, and signaling. J. Lipid Res. 50: S237-S242.
4. 2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J. Biol. Chem. 279: 48968-48975.
5. 2 from macrophage-like P388D1 cells. Isolation and characterization. J. Biol. Chem. 269: 9227-9233.
6. 2. J. Biol. Chem. 271: 30879-30885.
7. 2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages. J. Biol. Chem. 272: 29317-29321.
8. 2. A novel mechanism underlying arachidonic acid mobilization. J. Biol. Chem. 272: 1522-1526.
9. 2 mediates lymphocyte proliferation. J. Biol. Chem. 275: 35692-35698.
10. 2 augments spontaneous fatty acid release. J. Biol. Chem. 275: 18248-18258.
11. Smani, T., S. I. Zakharov, P. Csutora, E. Leno, E. S. Trepakova, and V. M. Bolotina. 2004. A novel mechanism for the store-operated calcium influx pathway. Nat. Cell Biol. 6: 113-120.
12. 2 expression on phospholipid content and composition, insulin secretion, and proliferation of INS-1 insulinoma cells. J. Biol. Chem. 281: 187-198.
13. 2 deficiency in mice: a model of human neurodegenerative disease. J. Neurosci. 28: 2212-2220.
14. 2β)-mull mice. Am. J. Pathol. 172: 868-881.
15. 2 produce spermatozoa with impaired motility and have greatly reduced fertility. J. Biol. Chem. 279: 38194-38200.
16. 2, is mutated in neurodegenerative disorders with high brain iron. Nat. Genet. 38: 752-754.
17. 2. J. Biol. Chem. 275: 9937-9945.
18. 2γ leads to alterations in mitochondrial lipid metabolism and function resulting in a deficient mitochondrial bioenergetic phenotype. J. Biol. Chem. 282: 34611-34622.
19. 2γ leads to alterations in hippocampal cardiolipin content and molecular species distribution, mitochondrial degeneration, autophagy, and cognitive dysfunction. J. Biol. Chem. 284: 35632-35644.
20. 2. J. Biol. Chem. 280: 14028-14041.
21. 2 in rat fibroblastic cells. J. Biol. Chem. 282: 20124-20132.
22. 2γ. J. Biol. Chem. 280: 26669-26679.
23. 2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E 2 biosynthesis. J. Biol. Chem. 275: 32775-32782.
24. Taniwaki, T., K. Haruna, H. Nakamura, T. Sekimoto, Y. Oike, T. Imaizumi, F. Saito, M. Muta, Y. Soejima, A. Utoh, et al. 2005. Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. Dev. Growth Differ. 47: 163-172.
25. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Physiol. Pharmacol. 37: 911-917.
26. Rouser, G., A. N. Siakotos, and S. Fleischer. 1966. Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots. Lipids. 1: 85-86.
27. Kamei, D., K. Yamakawa, Y. Takegoshi, M. Mikami-Nakanishi, Y. Nakatani, S. Oh-Ishi, H. Yasui, Y. Azuma, N. Hirasawa, K. Ohuchi, et al. 2004. Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1. J. Biol. Chem. 279: 33684-33695.
28. 2γ resulting in multiple gene products containing dual competing sites for mitochondrial or peroxisomal localization. Eur. J. Biochem. 271: 4709-4724.
29. Colvin, J. S., B. A. Bohne, G. W. Harding, D. G. McEwen, and D. M. Ornitz. 1996. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet. 12: 390-397.
30. Tourtellotte, W. G., and J. Milbrandt. 1998. Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. Nat. Genet. 20: 87-91.
31. Dabovic, B., Y. Chen, C. Colarossi, H. Obata, L. Zambuto, M. A. Perle, and D. B. Rifkin. 2002. Bone abnormalities in latent TGF-β binding protein (Ltbp)-3-null mice indicate a role for Ltbp-3 in modulating TGF-β bioavailability. J. Cell Biol. 156: 227-232.
32. Baribault, H., J. Danao, J. Gupte, L. Yang, B. Sun, W. Richards, and H. Tian. 2006. The G-protein-coupled receptor GPR103 regulates bone formation. Mol. Cell. Biol. 26: 709-717.
33. Lang, N. P., M. S. Tonetti, J. Suter, J. Sorrell, G. W. Duff, and K. S. Kornman. 2000. Effect of interleukin-1 gene polymorphisms on gingival inflammation assessed by bleeding on probing in a periodontal maintenance population. J. Periodontal Res. 35: 102-107.
34. Emery, P., and M. Salmon. 1991. The immune response. 2. Systemic mediators of inflammation. Br. J. Hosp. Med. 45: 164-168.
35. Kishimoto, T., S. Akira, and T. Taga. 1992. Interleukin-6 and its receptor: a paradigm for cytokines. Science. 258: 593-597.
36. Birkedal-Hansen, H. 1993. Role of cytokines and inflammatory mediators in tissue destruction. J. Periodontal Res. 28: 500-510.
37. Sjöblom, B., A. Salmazo, and K. Djinovi -Carugo. 2008. α-actinin structure and regulation. Cell. Mol. Life Sci. 65: 2688-2701.
38. Kang, Y. J. 2007. Antioxidant defense against anthracycline cardiotoxicity by metallothionein. Cardiovasc. Toxicol. 7: 95-100.
39. Takahashi, T., H. Shimizu, H. Morimatsu, K. Inoue, R. Akagi, K. Morita, and S. Sassa. 2007. Heme oxygenase-1: a fundamental guardian against oxidative tissue injuries in acute inflammation. Mini Rev. Med. Chem. 7: 745-753. (Pubitemid 47099174)
40. Jaiswal, A. K. 2000. Regulation of genes encoding NAD(P) H:quinone oxidoreductases. Free Radic. Biol. Med. 29: 254-262.
41. Velica, P., and C. M. Bunce. 2008. Prostaglandins in muscle regeneration. J. Muscle Res. Cell Motil. 29: 163-167.
42. 2α stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway. J. Cell Biol. 161: 111-118.
43. Schlame, M., D. Rua, and M. L. Greenberg. 2000. The biosynthesis and functional role of cardiolipin. Prog. Lipid Res. 39: 257-288.
44. Li, G., S. Chen, M. N. Thompson, and M. L. Greenberg. 2007. New insights into the regulation of cardiolipin biosynthesis in yeast: implications for Barth syndrome. Biochim. Biophys. Acta. 1771: 432-441.
45. Houtkooper, R. H., and F. M. Vaz. 2008. Cardiolipin, the heart of mitochondrial metabolism. Cell. Mol. Life Sci. 65: 2493-2506.
46. Schlame, M. 2008. Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes. J. Lipid Res. 49: 1607-1620.
47. Schlame, M., S. Shanske, S. Doty, T. König, T. Sculco, S. DiMauro, and T. J. Blanck. 1999. Microanalysis of cardiolipin in small biopsies including skeletal muscle from patients with mitochondrial disease. J. Lipid Res. 40: 1585-1592.
48. Xu, Y., M. Condell, H. Plesken, I. Edelman-Novemsky, J. Ma, M. Ren, and M. Schlame. 2006. A Drosophila model of Barth syndrome. Proc. Natl. Acad. Sci. USA. 103: 11584-11588.
49. Gu, Z., F. Valianpour, S. Chen, F. M. Vaz, G. A. Hakkaart, R. J. Wanders, and M. L. Greenberg. 2004. Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome. Mol. Microbiol. 51: 149-158.
50. Valianpour, F., R. J. Wanders, H. Overmars, P. Vreken, A. H. Van Gennip, F. Baas, B. Plecko, R. Santer, K. Becker, and P. G. Barth. 2002. Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060): a study in cultured skin fibroblasts. J. Pediatr. 141: 729-733.
51. Vreken, P., F. Valianpour, L. G. Nijtmans, L. A. Grivell, B. Plecko, R. J. Wanders, and P. G. Barth. 2000. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem. Biophys. Res. Commun. 279: 378-382.
52. Barth, P. G., F. Valianpour, V. M. Bowen, J. Lam, M. Duran, F. M. Vaz, and R. J. Wanders. 2004. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Am. J. Med. Genet. A. 126A: 349-354.
53. 2 in the pathogenesis of Barth syndrome. Proc. Natl. Acad. Sci. USA. 17: 2337-2341.
54. Malik, I., J. Turk, D. J. Mancuso, L. Montier, M. Wohltmann, D. F. Wozniak, R. E. Schmidt, R. W. Gross, and P. T. Kotzbauer. 2008. Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations. Am. J. Pathol. 172: 406-416.
55. Khateeb, S., H. Flusser, R. Ofir, I. Shelef, G. Narkis, G. Vardi, Z. Shorer, R. Levy, A. Galil, K. Elbedour, et al. 2006. PLA2G6 mutation underlies infantile neuroaxonal dystrophy. Am. J. Hum. Genet. 79: 942-948.
56. 2γ expression induces lipid peroxidation and cell death and sensitizes cells to oxidant-induced apoptosis. J. Lipid Res. 49: 1477-1487.
57. Gonzalvez, F., and E. Gottlieb. 2007. Cardiolipin: setting the beat of apoptosis. Apoptosis. 12: 877-885.
58. Esposito, L. A., J. E. Kokoszka, K. G. Waymire, B. Cottrell, G. R. MacGregor, and D. C. Wallace. 2000. Mitochondrial oxidative stress in mice lacking the glutathione peroxidase-1 gene. Free Radic. Biol. Med. 28: 754-766.
59. Nakagawa, Y. 2004. Initiation of apoptotic signal by the peroxidation of cardiolipin of mitochondria. Ann. N. Y. Acad. Sci. 1011: 177-184.
60. Leung, L., M. Kwong, S. Hou, C. Lee, and J. Y. Chan. 2003. Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress. J. Biol. Chem. 278: 48021-48029.
61. Cao, P. R., H. J. Kim, and S. H. Lecker. 2005. Ubiquitin-protein ligases in muscle wasting. Int. J. Biochem. Cell Biol. 37: 2088-2097.
62. Cai, D., J. D. Frantz, N. E. Tawa, Jr., P. A. Melendez, B. C. Oh, H. G. Lidov, P. O. Hasselgren, W. R. Frontera, J. Lee, D. J. Glass, et al. 2004. IKKβ/NF-kappaB activation causes severe muscle wasting in mice. Cell. 119: 285-298.
63. Li, Y. P., Y. Chen, A. S. Li, and M. B. Reid. 2003. Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am. J. Physiol. Cell Physiol. 285: C806-C812.
64. 2 on arachidonic acid release induced by reactive oxygen species. Arch. Biochem. Biophys. 392: 257-262.
65. 2-mediated repair of mitochondrial membrane peroxidation. Endocrinology. 151: 3038-3048.
66. 2 biosynthesis. J. Clin. Invest. 119: 1477-1488.
67. 2: an electrophilic trigger of cellular responses. Chem. Res. Toxicol. 21: 138-144.
68. Hunter, J. G., M. F. van Delft, R. A. Rachubinski, and J. P. Capone. 2001. Peroxisome proliferator-activated receptor γ ligands differentially modulate muscle cell differentiation and MyoD gene expression via peroxisome proliferator-activated receptor γ-dependent and -independent pathways. J. Biol. Chem. 276: 38297-38306.
69. Ueno, N., Y. Takegoshi, D. Kamei, I. Kudo, and M. Murakami. 2005. Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem. Biophys. Res. Commun. 338: 70-76. (Pubitemid 41540538)
70. Morita, I., M. Schindler, M. K. Reiger, J. C. Otto, T. Hori, D. L. DeWitt, and W. L. Smith. 1995. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J. Biol. Chem. 270: 10902-10908.
71. Kornmann, B., E. Currie, S. R. Collins, M. Schuldiner, J. Nunnari, J. S. Weissman, and P. Walter. 2009. An ER-mitochondria tethering complex revealed by a synthetic biology screen. Science. 325: 477-481.